You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Persistent/Recurrent Ovarian Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Oligometastatic Disease, Recurrent Ovary Cancer Trial (Stereotactic body radiotherapy)

Recruiting
  • Ovarian Neoplasms
  • +2 more
  • Stereotactic body radiotherapy
  • Campobasso, CB, Italy
  • +7 more
Sep 23, 2022

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte, Pasadena

Active, not recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Duarte, California
  • +1 more
Mar 17, 2022

Ovarian Clear Cell Carcinoma Trial in Wuhan (Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Apr 18, 2022

Ovarian Clear Cell Carcinoma, Gynecologic Cancer Trial in Boston (Lenvatinib, Pembrolizumab)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Gynecologic Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 13, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Ovarian Cancer, Recurrent Cancer Trial (CYH33)

Not yet recruiting
  • Ovarian Cancer
  • Recurrent Cancer
  • (no location specified)
Sep 5, 2021

Ovarian Cancer, Peritoneal Cavity Cancer Trial in Dallas (Ad5CMV-p53 gene)

Completed
  • Ovarian Cancer
  • Peritoneal Cavity Cancer
  • Ad5CMV-p53 gene
  • Dallas, Texas
    Simmons Cancer Center - Dallas
Jan 29, 2021

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (biological, drug, other)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 5, 2021

Ovarian Cancer, Tumors, Carcinoma Trial in Philadelphia (enzastaurin)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group 215-854-0770
Nov 24, 2020

Ovarian Cancer Trial in Worldwide (Ipatasertib, Cobimetinib, Trastuzumab Emtansine)

Recruiting
  • Ovarian Cancer
  • Tucson, Arizona
  • +60 more
Jan 20, 2023

Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Fluzopril Combined With Apatinib
  • (no location specified)
Oct 22, 2023

Participation Patterns Among Recurrent Ovarian Cancer Patients

Not yet recruiting
  • Recurrent Ovarian Cancer
    • San Francisco, California
      Power Life Sciences
    Sep 30, 2023

    Primary Peritoneal Carcinoma Trial in Baltimore (Tremelimumab, Olaparib)

    Terminated
    • Primary Peritoneal Carcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Apr 9, 2021

    Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)

    Active, not recruiting
    • Carcinosarcoma, Ovarian
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center, University of Oklahoma Health Sciences
    Sep 27, 2021

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

    Completed
    Has Results
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Bevacizumab
    • +3 more
    • Phoenix, Arizona
    • +44 more
    Jan 10, 2022

    Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

    Not yet recruiting
    • Recurrent Vulvar Cancer
    • +3 more
    • (no location specified)
    Jun 12, 2023

    Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

    Not yet recruiting
    • Recurrent Endometrial Carcinoma
    • Recurrent Ovarian Carcinoma
    • Biopsy
    • +5 more
    • (no location specified)
    Sep 29, 2022

    Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

    Not yet recruiting
    • Recurrent Ovarian Cancer
    • Pittsburgh, Pennsylvania
      Magee-Womens Research Institute / UPMC Magee Womens Hospital
    Jul 3, 2023

    A Prospective, Randomized Controlled Study of Cyclophosphamide,

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • Shijiazhuang, Hebei, China
      Hebei
    Aug 20, 2023

    Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

    Not yet recruiting
    • Recurrent Ovarian Cancer
    • (no location specified)
    Jan 27, 2023

    Cervical Cancer Trial (Sacituzumab Govitecan)

    Not yet recruiting
    • Cervical Cancer
    • Sacituzumab Govitecan
    • (no location specified)
    Apr 18, 2023

    Persistent, Recurrent, or Metastatic Cervical Cancer Trial in Shanghai (GLS-010, Placebo, paclitaxel)

    Not yet recruiting
    • Persistent, Recurrent, or Metastatic Cervical Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Hospital
    Apr 4, 2023

    Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

    Recruiting
    • Ovarian Cancer Recurrent
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Science and Peking Un
    Aug 23, 2023